skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Topics covered in your multiple myeloma disease include:

  • Patient-based forecast methodology for multiple myeloma
  • Patients diagnosed with symptomatic and asymptomatic multiple myeloma, by country
  • Top three regimens used for first-line treatment of SCT-eligible multiple myeloma patients, by country
  • Absolute growth in incident cases of multiple myeloma in the US, Japan, and five major EU markets, by country, 2014–34
  • Age-specific trends in incident cases of multiple myeloma in the US, Japan, and five major EU markets, by age group, 2014–34
  • Farydak for multiple myeloma – SWOT analysis
  • Datamonitor Healthcare’s drug assessment summary of Kyprolis in multiple myeloma
  • Keytruda Phase III trials in multiple myeloma